SCHEMBL2820104

SCHEMBL2820104

CCOC(=O)c1nc(-c2ccc(F)cc2)oc1Br

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TARBP2 Q15633 7/20 0.64
PDCD4 Q53EL6 1/20 0.56
ALDH1A1 P00352 4/20 0.52
KDM4E B2RXH2 3/20 0.52
HPGD P15428 2/20 0.52
KMT2A Q03164 1/20 0.52
HSD17B10 Q99714 1/20 0.52
TRPM8 Q7Z2W7 1/20 0.50
GABRA2 P47869 1/20 0.49
GABRB2 P47870 1/20 0.49
GAA P10253 1/20 0.47
LMNA P02545 2/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
MAPT P10636 2/20 0.43
PKM P14618 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11623692 0.86 TARBP2 (0.80) TARBP2PDCD4ALDH1A1KDM4EHPGD
SCHEMBL2559657 0.85 ALDH1A1 (0.51) TARBP2PDCD4ALDH1A1KDM4EHPGD
SCHEMBL27824160 0.82 TARBP2 (0.57) TARBP2PDCD4ALDH1A1KDM4EHPGD
SCHEMBL18003564 0.80 TARBP2 (0.70) TARBP2PDCD4ALDH1A1KDM4EHPGD
SCHEMBL2820916 0.80 GAA (0.51) TARBP2ALDH1A1HPGDKMT2AHSD17B10
SCHEMBL2565926 0.79 HDAC6 (0.44) TARBP2KMT2ANPC1RAB9AL3MBTL1
SCHEMBL28297264 0.78 TARBP2 (1.00) TARBP2PDCD4ALDH1A1KDM4EHPGD
SCHEMBL1002400 0.78 TP53 (0.46) TARBP2ALDH1A1KDM4EHPGDKMT2A
SCHEMBL29111790 0.78 TARBP2 (0.59) TARBP2PDCD4ALDH1A1KDM4EHPGD
SCHEMBL21541933 0.77 TARBP2 (0.55) TARBP2PDCD4ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER HONGU MITSUYA 2010-10-07 US disclosed
US-7759373-B2 Large conductance calcium-activated K channel opener MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-20 US disclosed
US-20040127527-A1 Large conductance calcium-activated k channel opener MITSUBISHI TANABE PHARMA CORPORATION (JP) 2004-07-01 US disclosed
EP-1432690-A2 IMIDAZOLE, THIAZOLE AND OXAZOLE DERIVATIVES AND THEIR USE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT AND/OR PREVENTION OF POLLAKIURIA OR URINARY INCONTINENCE Tanabe Seiyaku Co., Ltd. (JP) 2004-06-30 EP disclosed
WO-2002083111-A2 IMIDAZOLE, THIAZOLE AND OXAZOLE DERIVATIVES AND THEIR USE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT AND/OR PREVENTION OF POLLAKIURIA OR URINARY INCONTINENCE TANABE SEIYAKU CO., LTD. (JP) 2002-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER KCNN3, KCNN2, KCNN1 TARBP2 4002/4885PDCD4 4304/4885ALDH1A1 4600/4885
US-20040127527-A1 Large conductance calcium-activated k channel opener KCNN1, KCNN4, KCNN3 TARBP2 3732/4885PDCD4 3726/4885ALDH1A1 4245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.